In contrast, we also identified a subset of MLL-AF4-bound enhancers that were unique to MLLr ALL, which were associated with key oncogenes showing MLLr-specific transcriptional upregulation. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.